Cannabis Roundup: CGC, OGI, ACB, and HEXO


Oct. 11 2019, Published 3:49 p.m. ET

Today, President Donald Trump tweeted, “Good things are happening at China Trade Talk Meeting. Warmer feelings than in recent past, more like the Old Days. I will be meeting with the Vice Premier today. All would like to see something significant happen!” This tweet appears to have increased optimism among investors, driving the US stock market up. At 2:00 PM EDT, the S&P 500 Index and the Dow Jones Industrial Average were both up by 1.7%. Despite the surge in the broader equity market, the cannabis sector showed a mixed performance today.

The ETFMG Alternative Harvest ETF (MJ) was up by 0.4% at 1:57 PM EDT, while the Horizons Marijuana Life Sciences Index ETF (HMMJ) was down 0.9% at 1:44 PM EDT.

Article continues below advertisement

Canopy Growth hits a 52-week low

Today, MarketWatch reported that Jefferies downgraded Canopy Growth (CGC) (WEED) from “buy” to “hold.” Jefferies lowered its price target on Canopy Growth from 77 Canadian dollars to 25 Canadian dollars.

The Jefferies downgrade appears to have dragged the company’s stock down. Today, CGC hit a 52-week low of 25.82 Canadian dollars. At 1:44 PM EDT, the company was trading at 25.99 Canadian dollars, which implies a fall of 4.3% from its previous day’s closing price.

Earlier this month, Piper Jaffray, Compass Point, and CIBC also lowered their price targets for CGC stock. For more on these analysts’ ratings, please read Canopy Growth: Analysts Provide Target Price and Ratings.

OGI rises over 9.0%

Today, Jefferies upgraded OrganiGram Holdings (OGI) from “hold” to “buy.” However, the investment firm cut its price target for the stock from 10.50 Canadian dollars to 8.20 Canadian dollars. The new price target represents an upside potential of 127.1% from OGI’s October 10 closing price.

The Jefferies upgrade appears to have led OrganiGram stock to rise. At 1:45 PM EDT, the company was trading 9.7% higher. For analysts’ ratings on OGI, please read OrganiGram: Analysts’ Target Price and Ratings.

Article continues below advertisement

Aurora Cannabis trades in the red

After falling 9.3% yesterday, Aurora Cannabis (ACB) was trading 2.2% lower today at 1:46 PM EST. Today, Jefferies lowered its price target on ACB from 14 Canadian dollars to 7 Canadian dollars.

Jefferies’s new price target represents an upside of 41.1% from the company’s October 10 closing price. The slashing of its price target by 50% appear to have led to a fall in Aurora’s stock price. This year, Aurora has lost 26.8% of its stock value as of October 10.

However, the company continues to focus on preparing for the second phase of legalization in Canada. For more, please read Cannabis 2.0: Aurora’s Focus on Edibles.

HEXO falls another 6.4%

Yesterday, Hexo (HEXO) reported lower-than-expected preliminary revenue for the fourth quarter of fiscal 2020. The company also withdrew its guidance for fiscal 2020. Its lower-than-expected revenue led Hexo stock to fall by 23% yesterday. Today, the company’s stock fell again by 6.4% at 1:46 PM EDT.

Following the withdrawal of its revenue guidance today, Eight Capital downgraded the stock from “buy” to “neutral,” and it slashed its price target from $12 to $3.

Today, Cormark Securities and Canaccord Genuity also lowered their price targets. Eight Capital’s downgrade and analysts lowering their price targets appear to have led to a fall in the company’s stock price. However, Jefferies upgraded the stock from “underperform” to “hold.”


More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.